Shin Nippon Biomedical Laboratories, Ltd. (TYO:2395)
Japan flag Japan · Delayed Price · Currency is JPY
1,305.00
-17.00 (-1.29%)
Sep 11, 2026, 3:30 PM JST

TYO:2395 Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, TYO:2395 stock has a consensus rating of "Buy" and an average price target of ¥1,694. The average 1-year stock price forecast is 29.77% higher than the current stock price, while the lowest is ¥1,387 (+6.28%) and the highest is ¥2,000 (+53.26%).

Price Target: ¥1,694 (+29.77%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥1,387¥1,694¥1,694¥2,000
Change+6.28%+29.77%+29.77%+53.26%

Analyst Ratings

The average analyst rating for TYO:2395 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Aug '26
Strong Buy111111
Buy111000
Hold000111
Sell000000
Strong Sell000000
Total222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Nomura
No rating
Nomura
Hold
Maintains
¥1,280¥1,387
HoldMaintains¥1,280¥1,387+6.28%Aug 27, 2026
Unknown Analyst
Tokai-Tokyo Securities
No rating
Tokai-Tokyo Securities
Buy
Maintains
¥2,000
BuyMaintains¥2,000+53.26%May 26, 2026

Financial Forecast

Revenue This Year
38.48B
from 32.52B
Increased by 18.32%
Revenue Next Year
41.69B
from 38.48B
Increased by 8.34%
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
17.75B25.09B26.45B32.41B32.52B38.48B
Revenue Growth
17.46%41.37%5.42%22.54%0.34%18.32%
Operating Income
4.20B5.25B4.16B2.99B2.65B3.18B
Net Income
7.13B6.06B5.53B4.92B4.57B3.91B
Dividend / Share
30.0050.0050.0050.0050.0050.00
Dividend Growth
200.00%66.67%----
Free Cash Flow
2.47B-2.73B-7.43B-5.52B-1.80B-4.70B
No. Analysts
-----2
Financial currency is JPY.

Revenue Forecast

Revenue202720282029
High38.6B
Avg38.5B
Low38.4B

Revenue Growth

Revenue Growth202720282029
High
18.6%
Avg
18.3%
Low
18.1%

EPS Forecast

EPS202720282029
High-
Avg-
Low-

EPS Growth

EPS Growth20282029
High-
Avg-
Low-